期刊文献+

第3批缩宫素国家标准品的建立 被引量:1

Establishment of 3rd batch of national standard of oxytocin
原文传递
导出
摘要 目的建立首批HPLC含量测定用缩宫素国家标准品。方法第3批缩宫素国家标准品采用冻干制备。使用核磁共振和HPLC法对缩宫素进行结构确证;采用HPLC法测定待标品的质量分数,并测定待标品水分及氨基酸比值;以缩宫素USP对照品为标准,采用HPLC外标法和大鼠子宫法分别测定待标品的生物效价。结果经核磁共振和HPLC法确证缩宫素的结构;待标品水分含量为4.8%,各氨基酸比值均在限度范围内,经HPLC检测质量分数为99.69%;待标品经HPLC法测定每支含量为274 IU,经大鼠子宫法测定每支含量为275 IU。结论建立的待标品可作为第3批缩宫素国家标准品,供缩宫素效价测定及鉴别使用。 Objective To establish the first batch of national standard of oxytocin for high performance liquid chromatography(HPLC).Methods This batch of standard is prepared by freeze-drying.The structure of oxytocin was confirmed by NMR and HPLC.HPLC was used to determine the purity of the standard,moreover the water and amino acid ratio of the standard were determinated.The biological potency of oxytocin was determined by HPLC external standard method and rat uterus method against the oxytocin USP reference standard.Results The structure of oxytocin was confirmed by NMR and HPLC.The water content of the standard sample was 4.8%,the ratio of each amino acid was within the limit,and the mass fraction is 99.69%by HPLC.The content of oxytocin national standard was 274 IU per ampoule by HPLC and 275 IU per ampoule by rat uterus method.Conclusion This batch of standard substance can be used as the first batch of oxytocin national standard for HPLC content determination for oxytocin potency determination and HPLC identification.
作者 张媛 杨泽岸 孟长虹 李晓洁 高华 吴彦霖 ZHANG Yuan;YANG Zean;MENG Changhong;LI Xiaojie;GAO Hua;WU Yanlin(National Institutes for Food and Drug Control,Beijing 102629,China;Jiangsu Institute for Food and Drug Control,Nanjing 210008,China)
出处 《药物评价研究》 CAS 2023年第3期578-582,共5页 Drug Evaluation Research
关键词 缩宫素 高效液相色谱法 标准品 生物效价 大鼠子宫法 oxytocin high performance liquid chromatography standard biological potency rat uterus method
作者简介 第一作者:张媛,研究方向为药理学。E-mail:zhyuan_cn@126.com;通信作者:吴彦霖,研究方向为药理学。E-mail:wyljoe@126.com。
  • 相关文献

参考文献6

二级参考文献37

  • 1周玮,漆洪波.2019年ACOG剖宫产后阴道分娩指南解读[J].中国实用妇科与产科杂志,2019,0(12):1340-1344. 被引量:36
  • 2中国药典2010年版.二部[S].2010:附录29.
  • 3国家药典委员会.中国药典:二部[S]{H}北京:中国医药科技出版社,2010附录119.
  • 4欧洲药典委员会.欧洲药典:7.0,0</a>[S]20102653-2654.
  • 5国家药典委员会.中国药典:二部[S]{H}北京:中国医药科技出版社,2010附录130.
  • 6ChV 2010. The First Supplement[S]. 2010:310.
  • 7CHAIBVA FA, WALKER RB. Development and validation of a stability indicating analytical method for the quantitation of oxyto- ein in pharmaceutical dosage forms [ J ]. J Pharm Biomed Anal, 2007,43( 1 ) :179.
  • 8GARD JW, ALEXANDER JM, BAWDON RE, et al. Oxytocin prep- aration stability in several common obstetric intravenous solutions [ J ]. Am J Obstet Gynecol, 2002,186 (3) :496.
  • 9李海芳,钱德明.缩宫素生物效价测定实验的几点体会[J].中国药品标准,2008,9(4):247-249. 被引量:5
  • 10李湛君,杨昭鹏,徐康森.生物检定法与HPLC法测定重组人生长激素(rhGH)效价的相关性验证[J].药物分析杂志,1998,18(2):95-98. 被引量:6

共引文献52

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部